What Researchers Did
Researchers conducted a randomized controlled trial comparing hyperbaric oxygen therapy (HBOT) to pharmacological intervention in fibromyalgia patients with a history of traumatic brain injury.
What They Found
Hyperbaric oxygen therapy significantly reduced pain intensity compared to medication (p = 0.001), demonstrating a large net effect size (d = -0.95). HBOT also led to significant improvements in fibromyalgia symptoms, quality of life, and increased pain thresholds and conditioned pain modulation.
What This Means for Canadian Patients
This research suggests that HBOT could offer a new treatment option for Canadian patients with fibromyalgia following TBI, particularly for those who do not respond well to existing medications. It may provide an alternative approach to improve pain, quality of life, and other associated symptoms.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A limitation is that the study focused on fibromyalgia patients with a history of traumatic brain injury, which may limit generalizability to other fibromyalgia populations.